Bond markets accelerate but volatility ahead?
Redemptions from the low-rate Covid era are about to surge – will corporates find a favorable market for refinancing?
20m
3m
Healthy Debt Markets are Driving Deal Flow
RBC Capital Markets’ Rob Lamb and Patrick McDonald discuss the trends that have facilitated healthy debt capital market activity in 2024, and explore the strategies that can best support deals in a year marked by election uncertainty.
27m 3m
Investors Eye Canadian Energy as Game-Changing Projects Go Live
As long-promised infrastructure starts to bear fruit, Canada’s energy market is starting to attract serious investor attention. RBC’s experts reflect on the country’s prospects.
9m 2m
Why U.S. Banks Are Set for Strong Performance
In a shifting financial landscape, banks are emerging as compelling value investments, driven by modest GDP growth and anticipated Fed rate cuts. Co-Head of Global Financials Research, Gerard Cassidy, explores the latest trends in bank stocks, regulatory changes, and M&A opportunities.
23m 4m
Bringing Private Capital to Energy Transition Innovation
Access to capital is critical for the energy transition. Specialists who have helped RBC raise over $1bn of private investment for energy transition companies in the past 18 months join host Beatrix Pratte-Ness to assess the market. Start listening.
26m 3m
Energy M&A: A Game of Chess
RBC Global Energy’s Nick Woodruff and Tim Perry discuss the trends shaping the landscape of commodities, energy, and infrastructure investments coming out of RBC’s 2024 Energy, Power & Infrastructure Conference (EPIC) in New York.
20m 3m
How to Build and Sell a Biotech in 2024
With a combined deal value of $29bn under their belts this year, four CEOs reflect on what they’ve learned from their successes – and failures. Roberto Bellini (who sold BELLUS Health), Mark McKenna (Prometheus), Bill Meury (Karuna Therapeutics) and Dan O’Connor (Ambrx Biopharma) also consider the current market for biopharma M&A and what buyers are seeking today.
35m 3m
Healthcare Equities Outlook: Opportunities for Outperformance
Which areas of the healthcare industry have the biggest potential for equity market activity in 2024? Start listening.
16m 4m
The Role of Sport in Youth Mental Wellbeing
In recognition of Mental Health Awareness Month Wil Snape-Rogers, Executive Director, and Danielle Hundt, Chief Program Officer, of Play Rugby USA join Vito Sperduto to discuss how they are using the power of sport to help young people flourish—both mentally and physically.
26m
U.S. in Prime Position as Energy Sector Eyes New Growth
External forces are weighing heavily on energy markets in very different ways. While enforcement of merger competition rules puts strain on M&A deals, AI advances offer potential for both increased demand and business efficiencies. RBC Global Energy’s Nick Woodruff and Tim Perry consider the likely effects on the industry with host Vito Sperduto.
26m 3m
A ‘Goldilocks Era’ for Oil and Gas M&A
Oil and gas markets have reached a low- or no-growth business model, yet recent months have produced a surge in M&A activity not seen for a generation. Tim Perry and Nick Woodruff, of RBC’s Global Energy team, join Vito Sperduto to take the temperature of the sector and analyze the current state of energy valuations.
22m 4m
How private capital is reshaping Europe’s investment landscape
John Kolz, Global Co-Head, Equity Capital Markets, Paul Betts, Managing Director, M&A, Europe and Beatrix Pratte-Ness, Associate, M&A, Europe, explore key themes shaping private placement transactions across Europe, and the interplay between private and public markets and M&A activity.
14m
Tech’s IPO Comeback
After the tech IPO drought of 2023, what is the state of the market this year? Do software and AI companies have a path to go public? Jesse Chasse, MD and Head of Technology, Equity Capital Markets at RBC, joins Dan Nathan on the Okay, Computer podcast to analyze the prospects for a market revival.
5m
